These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20801762)

  • 21. Vigabatrin Toxicity in a Patient with Infantile Spasms Treated with Concomitant Hormonal Therapy.
    Lotan E; Bluvstein J; Zan E
    Isr Med Assoc J; 2020 Jul; 22(7):461-462. PubMed ID: 33236576
    [No Abstract]   [Full Text] [Related]  

  • 22. Are vigabatrin induced T2 hyperintensities in cranial MRI associated with acute encephalopathy and extrapyramidal symptoms?
    Dill P; Datta AN; Weber P; Schneider J
    Eur J Paediatr Neurol; 2013 May; 17(3):311-5. PubMed ID: 23199677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
    Lancet Neurol; 2005 Nov; 4(11):712-7. PubMed ID: 16239177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vigabatrin for the treatment of infantile spasms: final report of a randomized trial.
    Elterman RD; Shields WD; Bittman RM; Torri SA; Sagar SM; Collins SD
    J Child Neurol; 2010 Nov; 25(11):1340-7. PubMed ID: 20404353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible MRI Changes in an Infant with Epileptic Spasms on Low Dose Vigabatrin.
    Jain P; Alwadhi R; Kumar V
    Indian J Pediatr; 2016 Sep; 83(9):1049-50. PubMed ID: 26817464
    [No Abstract]   [Full Text] [Related]  

  • 26. Vigabatrin for infantile spasms.
    Pesaturo KA; Spooner LM; Belliveau P
    Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vigabatrin: 2008 update.
    Willmore LJ; Abelson MB; Ben-Menachem E; Pellock JM; Shields WD
    Epilepsia; 2009 Feb; 50(2):163-73. PubMed ID: 19230067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy of vigabatrin therapy for tuberous sclerosis with infantile spasms].
    Suzuki-Muromoto, S; Uematsu M; Sato H; Numata-Uematsu Y; Nakayama T; Kiluchi A; Kobayashi T; Hino-Fukuyo N; Kure S
    No To Hattatsu; 2016 Nov; 48(6):413-9. PubMed ID: 30010289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms.
    Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S
    J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial of vigabatrin in patients with infantile spasms.
    Lux AL; Edwards SW; Osborne JP; Hancock E; Johnson AL; Verity CM; Kennedy CR; O'Callaghan FJ; Newton RW
    Neurology; 2002 Aug; 59(4):648. PubMed ID: 12196676
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug approved to treat infantile spasms.
    Thompson CA
    Am J Health Syst Pharm; 2009 Oct; 66(19):1682. PubMed ID: 19767370
    [No Abstract]   [Full Text] [Related]  

  • 32. Vigabatrin: an antiepileptic drug with major benefits but significant adverse effects.
    Besag FM
    Curr Drug Saf; 2010 Jul; 5(3):188-90. PubMed ID: 20624131
    [No Abstract]   [Full Text] [Related]  

  • 33. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
    Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA
    Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vigabatrin monotherapy for infantile spasms.
    Gaily E
    Expert Rev Neurother; 2012 Mar; 12(3):275-86. PubMed ID: 22364326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the risk of vigabatrin-attributed visual field loss lower in infancy than in later life?
    Riikonen R
    Epilepsia; 2009 Aug; 50(8):2005-6. PubMed ID: 19682035
    [No Abstract]   [Full Text] [Related]  

  • 36. Randomized trial of vigabatrin in patients with infantile spasms.
    Elterman RD; Shields WD; Mansfield KA; Nakagawa J;
    Neurology; 2001 Oct; 57(8):1416-21. PubMed ID: 11673582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
    O'Callaghan FJ; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversible vigabatrin-induced life-threatening encephalopathy.
    Hernández Vega Y; Kaliakatsos M; U-King-Im JM; Lascelles K; Lim M
    JAMA Neurol; 2014 Jan; 71(1):108-9. PubMed ID: 24247994
    [No Abstract]   [Full Text] [Related]  

  • 39. Early treatment of Aicardi syndrome with vigabatrin can improve outcome.
    Chau V; Karvelas G; Jacob P; Carmant L
    Neurology; 2004 Nov; 63(9):1756-7. PubMed ID: 15534281
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of West syndrome with vigabatrin: clinical and electroencephalographic evaluation of 13 patients].
    Henriques-Souza AM; Ataide Junior L; Laurentino SG
    Arq Neuropsiquiatr; 2007 Mar; 65(1):144-49. PubMed ID: 17420838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.